Skip to main content
Research and analysis

English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) 2024 to 2025 report

The ESPAUR report includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation and awareness activities.

Updates to this page

From:
UK Health Security Agency
Published:
10 October 2014
Last updated:
13 May 2026
Show all updates

  1. Updates as listed in the Details section of the landing page. Added an extended HTML summary.

  2. Removed survey callout box.

  3. Main report: Introduction • Changes made to the text referring to the deprivation data included in Chapter 2 of the main report – page 8 Chapter 2 • Updates made to figures 2.4, 2.5 and 2.7– pages 21, 24 and 25 Chapter 3 • Improvement to table 3.3 format • Update to contributors section – page 303 Chapter 6 • Updated figure caption for Figure 6.2 to clarify time period the graph covers page 201 • Updated Figure 6.3 to remove gridlines and duplicated title – page 203 • Changes made to wording on international collaborations for eBug in main messages and future actions – page 194 and page 225 Chapter 9 • Updates to denominator population used to calculate percentages relating to use of ESPAUR report chapters – page 289 Annexe: Chapter 2 • Removal of text relating to calculation of age-sex standardised rates – page 20 Data tables: Chapter 2 • Update to 2024 rates in Figure 2.1 tab column M • Updates made to data for <1 and 1 to 4 age groups in the Figure 2.4, 2.5 and 2.7 tabs • Addition of estimated rate of resistant infections per 100,000 population to Figure 2.2 column D • Removal of blank Sheet 1 Chapter 3 • Update to table number for Table 58, 59 and 60 in the Contents tab (rows 76,77 and 78; column C). English Surveillance Programme for Antimicrobial Utilisation and Resistance 2024 to 2025 Infographics and accessibility text: • Case counts removed from Detections of C. auris in patient in England by UKHSA region, 2024 infographic – slide 14 • Percentage correction from 90 to 87% in Target training roll out: Reach and evaluation infographic – slide 39 • Wording change from ‘Partnered with a further seven countries’ to ‘Partnered with seven countries’ in e-Bug engagement 2024-2025 infographic – slide 42 Lay summary: Chapter 9 • Update to the number of stakeholders who contributed to this year’s report – page 11 • Updates percentages relating to use of ESPAUR report chapters – page 11

  4. Added report for 2024 to 2025 plus annexe, summary and data spreadsheets.

  5. Added survey request.

  6. Added 2023 to 2024 report and associated attachments.

  7. Added ESPAUR report 2022 to 2023: lay summary.

  8. Corrected percentage for general practice penicillin prescribing in executive summary.

  9. Added 2023 report and related documents.

  10. Added 2021 to 2022 report and related documents.

  11. Added ESPAUR 2020 to 2021 report and related documents, archiving 2019 to 2020.

  12. Attached report for 2019 to 2020 plus data tables and annex.

  13. Added ESPAUR 2018 to 2019 report and annexe and archived prior publications.

  14. Added link to ESPAUR report 2018 figures annexes.

  15. Added the updated 'ESPAUR report 2018' and data tables.

  16. New report added: ESPAUR Report 2018.

  17. Updated 2017 report and uploaded additional 2017 ESPAUR data files.

  18. Added ESPAUR report 2017.

  19. Uploaded report data tables.

  20. Uploaded 2016 report and executive summary.

  21. Corrected figure for bloodstream infections on p8.

  22. Added the 2015 report, appendices and slideset.

  23. First published.

Documents

ESPAUR report 2024 to 2025: extended summary

HTML

ESPAUR report 2024 to 2025

PDF, 10.6 MB, 295 pages

ESPAUR report 2024 to 2025: annexe

PDF, 841 KB, 49 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

ESPAUR report 2024 to 2025: lay summary

HTML

ESPAUR report 2024 to 2025: chapter 2 data tables

MS Excel Spreadsheet, 2.91 MB

ESPAUR report 2024 to 2025: chapter 3 data tables

MS Excel Spreadsheet, 2.56 MB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

ESPAUR report 2024 to 2025: infographics

PDF, 10.2 MB, 56 pages

ESPAUR report 2024 to 2025: infographics accessible text

HTML

Details

The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report sets a standard to compare antimicrobial use and resistance in successive years.

The report acts as a resource for commissioning and implementing antimicrobial stewardship policies in England.

Post-publication edits

Please note that the following post-publication edits were made in April 2026 to the ESPAUR report 2024-2025 and some of its supporting documents.

Main report

Introduction

Changes made to the text referring to private (non-NHS) antibiotic use in Chapter 3 of the main report (page 9).

Chapter 2

  • updates to Figures 2.10(a) and Figure 2.11 in the main report
  • updates to data in 2.10 and 2.11 tabs of chapter 2 spreadsheet

Chapter 3

  • update to Chapter 3 ‘Main messages’, ‘Box 3.1: Antibiotic prescribing through private (non-NHS) routes in England, January 2019 to December 2024’, and the ‘Antiparasitic consumption’ section following the identification of a coding error affecting data on private (non-NHS) antibiotic prescribing
  • update to contributors section (page 293)

Infographics

  • update to the ‘Total CPO rate per 100,000 population’ legend, and regional rates for ‘Regional notifications per 100,000 population of acquired carbapenemase-producing organisms and proportion of carbapenemase mechanisms in England, 2024’ infographic (slide 11)
  • case counts removed from ‘Detections of C. auris in patient in England by UKHSA region, 2024’ infographic (slide 14)
  • data updated on the ‘Antibiotic consumption through private (non-NHS) routes’ – ‘Antibiotic consumption through private (non-NHS) routes has continually increased’ (slide 19)
  • percentage correction from 90 to 87% in ‘Target training roll out: Reach and evaluation infographic’ (slide 39)
  • update to wording from ‘Partnered with a further seven countries’ to ‘Partnered with seven countries’ in ‘e-Bug engagement 2024-2025 infographic’ (slide 41)

Infographic accessibility text

The infographic accessibility text for has also been updated with data corrections for ‘Antibiotic consumption through private (non-NHS) routes has continually increased’.

Previous ESPAUR reports

Sign up for emails or print this page

Related content